Peritonitis Treatments

Find Peritonitis Treatments

Generic Name

Tobramycin

Brand Names

Bethkis, TOBI, TOBI Podhaler, TobraDex, Tobrex

FDA approval date: June 28, 1981

Classification: Corticosteroid

Form: Injection, Ointment, Inhalant, Suspension, Capsule, Solution

What is Bethkis (Tobramycin)?

BETHKIS is indicated for the management of cystic fibrosis patients with Pseudomonas aeruginosa. Safety and efficacy have not been demonstrated in patients under the age of six years, patients with FEV 1 less than 40% or greater than 80% predicted, or patients colonized with Burkholderia cepacia. BETHKIS is an inhaled aminoglycoside antibacterial indicated for the management of cystic fibrosis patients with Pseudomonas aeruginosa. Safety and efficacy have not been demonstrated in patients under the age of six years, patients with a forced expiratory volume in one second less than 40% or greater than 80% predicted, or patients colonized with Burkholderia cepacia.

Approved To Treat

Top Global Experts

View All

Save this treatment for later

Not sure about your diagnosis?

Check Your Symptoms

Tired of the same old research?

Check Latest Advances

Related Clinical Trials

Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT - A Multicenter Randomized Control Trial

Enrollment Status: Recruiting

Publish Date: May 26, 2026

Intervention Type: Drug

Study Phase: Phase 3

Summary: The proposed study is a multi-center, prospective randomized controlled trial comparing current standard of care treatment to the SEXTANT treatment protocol in patients with Type III open fractures of the tibia and IIIB fractures of the ankle and hindfoot.

A Randomized Controlled Trial Comparing Antibiotic Cement Bead Pouch Versus Negative Pressure Wound Therapy for the Management of Severe Open Tibia Fracture Wounds

Enrollment Status: Recruiting

Publish Date: May 05, 2026

Intervention Type: Device, Drug

Study Phase: Phase 3

Summary: The Beads vs Vac trial is a multi-centre randomized controlled trial of 312 participants with a severe open tibia fracture requiring multiple irrigation and debridement surgeries. Eligible participants will be randomized to receive either an antibiotic bead pouch or negative pressure wound therapy (NPWT) for their temporary open fracture wound management. Outcomes will be assessed at 6 weeks, 3 mo...

A Double-Blind, Active-Controlled, Multiple-Ascending Dose, Phase 1b/2a Study of Aerosolized RSP-1502 Delivered Via the PARI LC Plus® Nebulizer in Subjects With Cystic Fibrosis and Chronic Pseudomonas Aeruginosa Lung Infection

Enrollment Status: Recruiting

Publish Date: December 29, 2025

Intervention Type: Drug

Study Phase: Phase 1/Phase 2

Summary: A double-blind, active-controlled, multiple-ascending dose, safety study of aerosolized RSP-1502 in subjects with cystic fibrosis Pseudomonas aeruginosa lung infection.

View All Clinical Trials